Australia will play a key role in protecting Canadians in the event of a future influenza pandemic under a new agreement between CSL Seqirus and the Canadian government.
CSL Seqirus to supply Canada with pandemic influenza vaccines from new Melbourne facility
March 5, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Medical research powering Australia’s health and economic future
March 31, 2026 - - Latest News -
A silent crisis in plain sight as arthritis burden grows while research funding falls behind
March 31, 2026 - - Latest News -
A new opportunity for biosimilars as sector leaders gather in Canberra
March 31, 2026 - - Latest News -
Those who recognise and respond to the reality will be better positioned to shape reforms
March 31, 2026 - - Latest News -
Alterity Therapeutics updates investors on key meeting with US regulator
March 30, 2026 - - Australian Biotech -
Aroa Biosurgery reports promising trial milestone for advanced wound treatment
March 30, 2026 - - Australian Biotech -
Genetic Signatures reshapes its business to cut costs and drive growth
March 30, 2026 -
